These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8305257)

  • 1. [Value of ultrasonography in the early diagnosis of hepatocellular carcinoma].
    Martínez Cerezo FJ; Puig M; Martínez Nogueras A; Tomás A; Pamplona J; Guarner C; Balanzó J; Enríquez J; Vilardell F
    Rev Esp Enferm Dig; 1993 Nov; 84(5):311-4. PubMed ID: 8305257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of ultrasonography in the early diagnosis of hepatocarcinoma in patients with liver cirrhosis].
    García Gullón C; Rendón Unceta P; Martín Herrera L; Soria de la Cruz MJ; Macías MA; Alcaín G
    Rev Esp Enferm Dig; 1995 Nov; 87(11):798-801. PubMed ID: 8534535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults.
    Lu SN; Wang JH; Chen PF; Tung HD; Tseng PL; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen YD; Tsai LS; Chen TH
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1813-21. PubMed ID: 18628436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early detection of hepatocellular carcinoma--high risk group and mass survey].
    Tanikawa K
    Gan To Kagaku Ryoho; 1993 May; 20(7):864-70. PubMed ID: 8387756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
    Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
    Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F
    Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Community-based hepatocellular carcinoma screening in seven townships in Taiwan].
    Chen CJ; Lu SN; You SL; Wu MH; Wang LY; Lee LT; Huang GT; Yang PM; Lee HS
    J Formos Med Assoc; 1995 Dec; 94 Suppl 2():S94-102. PubMed ID: 8672950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Motoyoshi Y; Shibata H; Eguchi K
    Oncol Rep; 2005 Oct; 14(4):999-1003. PubMed ID: 16142364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can hepatocellular cancer screening increase the proportion of long-term survivors?
    Gannon CJ; Izzo F; Aloia TA; Pignata S; Nasti G; Vallone P; Orlando R; Scordino F; Curley SA
    Hepatogastroenterology; 2009; 56(93):1152-6. PubMed ID: 19760960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
    Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW
    Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
    Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis and improved survival with screening for hepatocellular carcinoma].
    Youk CM; Choi MS; Paik SW; Ahn BH; Lee JH; Koh KC; Yoo BC; Rhee JC
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):116-23. PubMed ID: 12824751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].
    Jia HL; Xing XJ; Ye QH; Qin LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.